• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

AAP releases 2016 recommendations for childhood and adolescent immunizations

byMohammad MertabanandCordelia Ross
February 1, 2016
in Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Ad26.RSV.preF-RSV vaccination prevents RSV infection in older adults

RSV prefusion F protein vaccine is safe and effective in preventing RSV infection

Mental health may not play a role in vaccine uptake in high-income settings

The American Academy of Pediatrics (AAP) has published the newest recommendations for immunizations of children and adolescents. These changes include: the grouping of routinely recommended vaccines; updates to H influenza type b vaccine, Human papilloma virus (HPV) vaccine, Meningococcal B vaccine; and some stylistic modifications that make the schedule easier to follow.

Statement Rundown: The AAP published the new 2016 schedule for childhood and adolescent immunizations. This schedule is revised annually to reflect the US Food and Drug Administration’s most current recommendations.

The following changes to the schedule are recommended:

  • Routinely recommended vaccines have been grouped from earliest age to older ages of administration (under Recommended Immunization Schedule for Persons Ages 0 Through 18 Years).
  • H influenza type b: this vaccine is now recommended for high-risk children between the ages of 5 years through 18 years.
  • HPV has been changed to HPV9, reflecting the new designation. In addition, it is now recommended for children ages 9 to 10 years with a history of sexual abuse, indicating their high risk status.
  • Meningococcal B is now added to the schedule for high risk individuals at 10 years of age and non-high risk individuals ages 16 through 18.
  • Pneumococcal polysaccharide is no longer a routine recommendation for any population.

Footnotes contain recommendations for routine vaccinations, catch-up vaccinations, and vaccination of high-risk children and adolescents.

Click to read the policy statement, published today in Pediatrics

Relevant Readings: American Academy of Pediatrics Immunization Schedules and Parent-friendly vaccine schedule for children and adolescents

Tags: general pediatricsvaccinationvaccine schedule
Previous Post

Increased fiber in young adulthood may lower breast cancer risk

Next Post

2 Minute Medicine Rewind February 1, 2016

RelatedReports

Clinical practice guidelines linked to improved bronchiolitis outcomes
Infectious Disease

Ad26.RSV.preF-RSV vaccination prevents RSV infection in older adults

February 24, 2023
New AAP guidelines against albuterol for bronchiolitis
Infectious Disease

RSV prefusion F protein vaccine is safe and effective in preventing RSV infection

February 23, 2023
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Psychiatry

Mental health may not play a role in vaccine uptake in high-income settings

February 21, 2023
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse
Wellness

Wellness Check: Mental Health

February 16, 2023
Next Post
Delaying intrathecal therapy in leukemia may preclude need for cranial radiotherapy

2 Minute Medicine Rewind February 1, 2016

Text message reminders increase second-dose pediatric flu vaccine uptake

Mobile text messaging may improve medication adherence

Few high school students, young adults get HIV testing

Two novel HIV vaccines demonstrate safety and immunogenicity

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Synergistic interaction between risk burden and genetics for atrial fibrillation development
  • Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma
  • Specific histopathologic renal lesions may be associated with increased risk of cardiovascular disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options